SHANNON CLARK: Open Payments
NPI 1811569270 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 21 payments from 10 companies in 2025. Trend: 2023 $710 · 2024 $556 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $140 |
| ABBVIE INC. | 2 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Janssen Biotech, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| GENZYME CORPORATION | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| Organon LLC | 3 | $9 |
Products named: Bimzelx, SKYRIZI, BLU-U, TREMFYA, Sotyktu, LIBTAYO, Zoryve, DUPIXENT.
Industry payments across OK — which companies pay providers there.
